| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.25 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 0.0002 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.24 | 0.0003 |